Accelerate drug development           Proteomics technology           

 Research Programs

Intrinsic Bioprobes, Inc. is engaged in ongoing research programs that are generating a body of knowledge about proteins associated with healthy populations and major diseases. The information gathered from the large-scale population screening efforts currently undertaken at IBI will inevitably shed light on processes and specific protein modulations that are result of the onset and development of diseases such as cancer, cardiovascular diseases, and neurodegenerative disorders. At the same time, IBI’s technologies can be also used to monitor the organism response to drug and therapeutic treatment.

Learn more about IBI's research into the following diseases:
Cardiovascular Disease
Neurodegenerative Disorders
Infectious Diseases

Explore this section
Biomarker discovery
Population Proteomics
Research Programs

Related information
Proteomics technology
Request information

Home | Sitemap | Directions | Literature